Status:
COMPLETED
Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk
Lead Sponsor:
University of Belgrade
Collaborating Sponsors:
Centre of Research Excellence in Nutrition and Metabolism
Conditions:
Cardiovascular Risk Factor
Metabolic Syndrome
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
This cross-over study investigates health effects of dietary intake of whole walnuts towards cardiovascular risk factors in adults under low cardiovascular risk. Investigators hypothesize that daily ...
Detailed Description
Recent literature data raise important questions on the beneficial effect of dietary fats. Dietary intake of nuts, although with high caloric burden, is however characterized with high intake of fatty...
Eligibility Criteria
Inclusion
- Presence of at least one of the following criteria, formerly assessed through routine medical examination:
- dyslipidemia, defined as the presence of either: elevated total cholesterol (\>5.2 mmoL/L), and/or elevated LDL-cholesterol (\>3.4 mmoL/L), and/or elevated triglycerides (\>1.7 mmoL/L), and/or decreased HDL-cholesterol (\<1.6 mmoL/L)
- elevated blood pressure (systolic/diastolic ≥120/80 mmHg), or regular anti-hypertension therapy
Exclusion
- presence of allergy on any nuts
- presence of any chronic disease, excluding following conditions: hypertension and diabetes mellitus type 2
- smoking
- statin therapy
- pregnancy and/or lactation
Key Trial Info
Start Date :
April 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2017
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03227497
Start Date
April 21 2017
End Date
July 15 2017
Last Update
July 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade
Belgrade, Serbia, 11000